Substituted spirooxindoles
US9822128B1 · kind B1 · utility
Inventors
Key dates
| Filing date | Jun 1, 2017 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Jun 1, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The substituted spirooxindoles are MDM2-p53 inhibitors bearing a benzylidine (styryl) arm and have a complex fused ring system ideally suited for binding to the MDM2 protein, thereby interrupting its protein-protein interaction (PPI). Sixteen compounds, designated 4a-4p, were synthesized in a simple smooth method using an asymmetric 1,3-dipolar reaction as the key step. Testing showed that the compounds exhibit anti-cancer activity against various forms of cancer cells affecting humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.